BioCentury
ARTICLE | Clinical News

Cambia diclofenac regulatory update

April 2, 2012 7:00 AM UTC

Health Canada approved Cambia diclofenac from Stellar's Tribute Pharmaceuticals subsidiary for the acute treatment of migraine attacks with or without aura in adults. The company plans to launch the p...